Rupenthal ID - Search Results

1

Drug delivery to the lens for the management of cataracts.

Thrimawithana TR, Rupenthal ID, Räsch SS, Lim JC, Morton JD, Bunt CR. Thrimawithana TR, et al. Among authors: rupenthal id. Adv Drug Deliv Rev. 2018 Feb 15;126:185-194. doi: 10.1016/j.addr.2018.03.009. Epub 2018 Mar 28. Adv Drug Deliv Rev. 2018. PMID: 29604375 Review.

2

In vitro release characteristics and cellular uptake of poly(D,L-lactic-co-glycolic acid) nanoparticles for topical delivery of antisense oligodeoxynucleotides.

Chen YS, Alany RG, Young SA, Green CR, Rupenthal ID. Chen YS, et al. Among authors: rupenthal id. Drug Deliv. 2011 Sep-Oct;18(7):493-501. doi: 10.3109/10717544.2011.589088. Epub 2011 Jun 22. Drug Deliv. 2011. PMID: 21696294

3

Characterization and evaluation of β-glucan formulations as injectable implants for protein and peptide delivery.

Jacobs S, Bunt CR, Wu Z, Lehr CM, Rupenthal ID. Jacobs S, et al. Among authors: rupenthal id. Drug Dev Ind Pharm. 2012 Nov;38(11):1337-43. doi: 10.3109/03639045.2011.650646. Epub 2012 Feb 3. Drug Dev Ind Pharm. 2012. PMID: 22300392

4

Dendrimers for gene delivery--a potential approach for ocular therapy?

Chaplot SP, Rupenthal ID. Chaplot SP, et al. Among authors: rupenthal id. J Pharm Pharmacol. 2014 Apr;66(4):542-56. doi: 10.1111/jphp.12104. Epub 2013 Jul 19. J Pharm Pharmacol. 2014. PMID: 24635556 Review.

5

Implants for drug delivery to the posterior segment of the eye: a focus on stimuli-responsive and tunable release systems.

Yasin MN, Svirskis D, Seyfoddin A, Rupenthal ID. Yasin MN, et al. Among authors: rupenthal id. J Control Release. 2014 Dec 28;196:208-21. doi: 10.1016/j.jconrel.2014.09.030. Epub 2014 Oct 13. J Control Release. 2014. PMID: 25307997 Review.

6

Ocular delivery systems for topical application of anti-infective agents.

Duxfield L, Sultana R, Wang R, Englebretsen V, Deo S, Rupenthal ID, Al-Kassas R. Duxfield L, et al. Among authors: rupenthal id. Drug Dev Ind Pharm. 2016 Jan;42(1):1-11. doi: 10.3109/03639045.2015.1070171. Epub 2015 Aug 27. Drug Dev Ind Pharm. 2016. PMID: 26325119 Review.

7

Development of gatifloxacin-loaded cationic polymeric nanoparticles for ocular drug delivery.

Duxfield L, Sultana R, Wang R, Englebretsen V, Deo S, Swift S, Rupenthal I, Al-Kassas R. Duxfield L, et al. Pharm Dev Technol. 2016 Mar;21(2):172-9. doi: 10.3109/10837450.2015.1091839. Epub 2015 Oct 12. Pharm Dev Technol. 2016. PMID: 26794936

8

Cytotoxicity considerations and electrically tunable release of dexamethasone from polypyrrole for the treatment of back-of-the-eye conditions.

Ramtin A, Seyfoddin A, Coutinho FP, Waterhouse GI, Rupenthal ID, Svirskis D. Ramtin A, et al. Among authors: rupenthal id. Drug Deliv Transl Res. 2016 Dec;6(6):793-799. doi: 10.1007/s13346-016-0284-0. Drug Deliv Transl Res. 2016. PMID: 26887593

9

Light-responsive in situ forming injectable implants for effective drug delivery to the posterior segment of the eye.

Bisht R, Jaiswal JK, Chen YS, Jin J, Rupenthal ID. Bisht R, et al. Among authors: rupenthal id. Expert Opin Drug Deliv. 2016 Jul;13(7):953-62. doi: 10.1517/17425247.2016.1163334. Epub 2016 Mar 24. Expert Opin Drug Deliv. 2016. PMID: 26967153 Review.

10

Ocular drug delivery-eye on innovation.

Rupenthal ID, O'Rourke M. Rupenthal ID, et al. Drug Deliv Transl Res. 2016 Dec;6(6):631-633. doi: 10.1007/s13346-016-0335-6. Drug Deliv Transl Res. 2016. PMID: 27766597 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

98 results

Search Page